Renaissance Capital logo

PLTNU News

Renaissance Capital's November IPO Market Update

ACRV

It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain Atour Lifestyle Holdings (ATAT). Two small issuers also slipped through the IPO window despite increased scrutiny from regulators....read more

US IPO Weekly Recap: Chinese hotel chain leads a 3 IPO week

INTS

Three IPOs and one SPAC began trading this past week, though neither of the scheduled biotechs made it to market as Intensity Therapeutics (INTS) postponed and Acrivon Therapeutics (ACRV) delayed its pricing. One IPO and two SPACs submitted initial filings. In the pipeline, large IPOs KinderCare Learning Companies (KLC),...read more

APAC-focused SPAC Plutonian Acquisition prices $50 million IPO

Plutonian Acquisition, a blank check company targeting metaverse tech, tourism, and e-commerce in the APAC region, raised $50 million by offering 5 million units at $10. Each unit consists of one share of common stock, one warrant exercisable at $11.50, and one right to receive one-sixth of a share upon the consummation of an initial business combination. The trust will be...read more

Archived Headlines